Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$2.19B |
| 2 |
GE Vernova
GEV
|
+$1.16B |
| 3 |
Meta Platforms (Facebook)
META
|
+$501M |
| 4 |
Palantir
PLTR
|
+$451M |
| 5 |
DoorDash
DASH
|
+$411M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.22B |
| 2 |
Ascendis Pharma A/S
ASND
|
+$866M |
| 3 |
Applovin
APP
|
+$690M |
| 4 |
DAY
Dayforce
DAY
|
+$576M |
| 5 |
Workday
WDAY
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.5% |
| 2 | Healthcare | 20.49% |
| 3 | Industrials | 11.17% |
| 4 | Consumer Discretionary | 9.27% |
| 5 | Communication Services | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
CBRE Group
CBRE
$40.8B
| $157M | 0.08% |
1,162,260
+711,399
| +158% | +$108M |
|
227
Tarsus Pharmaceuticals
TARS
$2.56B
| $157M | 0.08% |
2,240,963
+310,638
| +16% | +$21.7M |
|
228
Cardinal Health
CAH
$53.4B
| $155M | 0.07% |
735,467
+559,450
| +318% | +$120M |
|
229
EOG Resources
EOG
$78B
| $154M | 0.07% |
1,063,813
+611,036
| +135% | +$74.2M |
|
230
SPX Corp
SPXC
$11B
| $153M | 0.07% |
765,245
+42,921
| +6% | +$9.22M |
|
231
Fabrinet
FN
$17.1B
| $152M | 0.07% |
291,659
+40,090
| +16% | +$20.4M |
|
232
Cisco
CSCO
$450B
| $152M | 0.07% |
1,956,094
+81,400
| +4% | +$6.37M |
|
|
BELFB
233
Bel Fuse Inc Class B
BELFB
$3.88B
| $151M | 0.07% |
760,141
+140,804
| +23% | +$29.4M |
|
234
Tyra Biosciences
TYRA
$1.82B
| $149M | 0.07% |
3,890,589
+955,147
| +33% | +$30.9M |
|
235
Biohaven
BHVN
$2.16B
| $148M | 0.07% |
17,534,612
+16,127,247
| +1,146% | +$176M |
|
236
Janus Henderson AAA CLO ETF
JAAA
$29.1B
| $148M | 0.07% |
2,941,973
+1,775,654
| +152% | +$89.9M |
|
237
Zurn Elkay Water Solutions
ZWS
$8.07B
| $148M | 0.07% |
3,303,293
-507,134
| -13% | -$24.2M |
|
238
Ziff Davis
ZD
$1.9B
| $148M | 0.07% |
3,526,329
+92,496
| +3% | +$3.4M |
|
239
OneMain Financial
OMF
$6.9B
| $146M | 0.07% |
2,729,862
+195,591
| +8% | +$11.6M |
|
240
Teck Resources
TECK
$29.5B
| $145M | 0.07% |
2,809,272
-755,460
| -21% | -$40.4M |
|
241
Teva Pharmaceuticals
TEVA
$35.9B
| $145M | 0.07% |
4,816,657
+72,880
| +2% | +$2.34M |
|
242
Teradyne
TER
$54.8B
| $144M | 0.07% |
486,919
-196,881
| -29% | -$54.9M |
|
243
Dollar Tree
DLTR
$23.1B
| $141M | 0.07% |
1,290,507
-323,533
| -20% | -$39.5M |
|
244
Amcor
AMCR
$20.6B
| $141M | 0.07% |
3,545,337
+1,140,987
| +47% | +$50.5M |
|
|
CNTA
245
DELISTED
Centessa Pharmaceuticals
CNTA
| $139M | 0.07% |
3,492,977
-600,631
| -15% | -$15.4M |
|
246
Apollo Global Management
APO
$70.7B
| $139M | 0.07% |
1,244,061
+115,141
| +10% | +$14.3M |
|
|
SNDK
247
Sandisk
SNDK
$213B
| $138M | 0.07% |
217,521
+34,285
| +19% | +$19.4M |
|
248
Sotera Health
SHC
$4.95B
| $131M | 0.06% |
9,162,191
+2,390,132
| +35% | +$39.7M |
|
249
T-Mobile US
TMUS
$193B
| $131M | 0.06% |
622,311
-504,218
| -45% | -$104M |
|
250
Cognex
CGNX
$10.3B
| $130M | 0.06% |
2,660,411
+1,190,434
| +81% | +$55.6M |
|
Similar funds
Janus Henderson Group's Q1 2026 Portfolio in Review
As of Q1 2026, Janus Henderson Group held 2,488 positions worth $209B, down 6.2% from $223B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Janus Henderson Group's Q1 2026 filing shows 82 new, 739 increased, 627 reduced and 81 closed positions. Its largest new stake was Forgent Power Solutions: 7,769,612 shares worth $227M. The largest sale was Microsoft, an estimated $1.22B.
By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 35% a quarter earlier, followed by Healthcare and Industrials.
- Janus Henderson Group's largest Q1 2026 buy was Forgent Power Solutions: 7,769,612 shares worth $227M.
- Janus Henderson Group added most to AstraZeneca in Q1 2026, an estimated $2.19B increase.
- Janus Henderson Group's biggest Q1 2026 reduction was Microsoft, cutting an estimated $1.22B.
- Janus Henderson Group fully exited Ascendis Pharma A/S in Q1 2026, selling an estimated $866M.
- Janus Henderson Group's ten largest holdings make up 30% of its $209B portfolio in Q1 2026.
- Janus Henderson Group opened 82 new positions and closed 81 in Q1 2026.
- Janus Henderson Group's portfolio value fell 6.2% quarter-over-quarter to $209B.
Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.